Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways
Abstract
Share and Cite
Aguilar, D.; Bosacoma, A.; Blanco, I.; Tura-Ceide, O.; Serrano-Mollar, A.; Barberà, J.A.; Peinado, V.I. Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. Life 2022, 12, 887. https://doi.org/10.3390/life12060887
Aguilar D, Bosacoma A, Blanco I, Tura-Ceide O, Serrano-Mollar A, Barberà JA, Peinado VI. Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. Life. 2022; 12(6):887. https://doi.org/10.3390/life12060887
Chicago/Turabian StyleAguilar, Daniel, Adelaida Bosacoma, Isabel Blanco, Olga Tura-Ceide, Anna Serrano-Mollar, Joan Albert Barberà, and Victor Ivo Peinado. 2022. "Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways" Life 12, no. 6: 887. https://doi.org/10.3390/life12060887
APA StyleAguilar, D., Bosacoma, A., Blanco, I., Tura-Ceide, O., Serrano-Mollar, A., Barberà, J. A., & Peinado, V. I. (2022). Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. Life, 12(6), 887. https://doi.org/10.3390/life12060887

